Pharmaceutical News

RSS

Senate Health Committee to begin reform mark up today, finance to follow next week

Senate Democrats are scrambling to reduce the price tag of reform proposals, which initial estimates place at $1.6 trillion, The Wall Street Journal reports.

18 Jun 2009

Medical schools improve conflict of interest policies, but widespread problems remain

According to the latest ratings of two watchdog groups, medical schools are "improving their conflict-of-interest policies to police their ties with drug and medical-device makers. But more than half the schools still have inadequate policies or no policies at all," the Wall Street Journal's Health Blog reports.

18 Jun 2009

House bill may target drugmakers' advertising tax breaks

Rep. Charles Rangel, D-N.Y., says the House Ways and Means Committee may seek to raise money for health reform by imposing a $37 billion tax on drugmaker's advertisements, Bloomberg reports: "As lawmakers seek ways to pay for a health-care overhaul, 'one thing that's not off the table is you can pick up $37 billion knocking out the deduction for advertising' for prescription drugs,'" Rangel said. The idea is among several proposals by Democratic legislators to raise reform money (Donmoyer, 6/16).

18 Jun 2009

Circadian Technologies granted significant European patent

Circadian Technologies Limited (ASX:CIR) announced today that its subsidiary company, Vegenics Limited, has been granted European Patent 1749836 covering the use of VEGF-D protein and antibodies to VEGF-D in a broad spectrum of therapeutic indications, including the treatment of cancer.

17 Jun 2009

Sinovac completes construction of H1N1 virus seed bank

Sinovac Biotech announced today that it has completed construction of the H1N1 virus seed bank necessary to produce a virus antigen.

16 Jun 2009

GlaxoSmithKline to cut some drug costs in emerging markets

GlaxoSmithKline (GSK) plans to decrease the prices of many of its leading medicines in emerging markets following the success of a pilot program in the Philippines, Andrew Witty, GSK's chief executive, said, Financial Times reports. Witty said the price cuts are part of an effort to diversify and expand globally.

15 Jun 2009

Drugstores group sues Delaware over Medicaid cutbacks

Walgreen Co.'s member organization in Delaware has "filed a suit against the state to put a stop to Medicaid rate cuts" just one week after "Walgreens announced it will stop filling prescriptions of brand-name medications for patients on Medicaid" in Delaware, the News Journal reports.

13 Jun 2009

India to promote drugs in Africa after fake Chinese drugs 'made in India' seized

India launched a project to promote its $10.7 billion pharmaceutical industry in Africa after fake drugs labeled "Made in India," but with actual origins in China were seized on the continent, IANS/Hindu reports.

13 Jun 2009

FDA issues health advisory on Levemir insulin

The U.S. Food and Drug Administration has learned that some stolen vials of the long-acting insulin Levemir made by Novo Nordisk Inc. have reappeared and are being sold in the U.S. market.

13 Jun 2009

FDA approves injectable Ibuprofen

The U.S. Food and Drug Administration today approved Caldolor, the first injectable dosage form of the common pain medication ibuprofen, to treat pain and fever.

11 Jun 2009

New drug for muscle degenerating diseases shows great promise

A new drug being studied for the treatment of muscle degenerating diseases has shown promising results. According to a study published today in the British Journal of Pharmacology, Debio 025 is as effective as current drugs but, crucially, does not cause unwanted immunosuppressive effects.

10 Jun 2009

Innovative partnership targets cancer-causing 'chaperones'

Cancer Research Technology (CRT) and The Institute of Cancer Research (ICR) today announced a major research collaboration with AstraZeneca. The three partners will combine their expertise to discover and develop potential new anti-cancer drugs to target molecular "chaperones" which support the growth of cancer cells.

10 Jun 2009

Medical industry showers Department of Defense with free travel

The health care industry funded "8,700 trips by Department of Defense personnel" from 1998 to 2007, at a cost of more than $10 million, the Center for Public Integrity reports.

10 Jun 2009

GlaxoSmithKline opens pneumonia vaccine plant In Singapore

Drug maker GlaxoSmithKline (GSK) on Tuesday opened a $600 million plant in Singapore that is slated to begin producing vaccines to fight pneumonia-causing bacteria in 2011, Reuters reports.

10 Jun 2009

Sinovac begins production of H1N1 vaccine

Sinovac Biotech Ltd. announced today that it begins the production of a vaccine against influenza A (H1N1) virus. The virus seed was received from U.S. CDC and was delivered to the company on June 8, 2009.

9 Jun 2009

New antibiotics could come from a DNA binding compound that kills bacteria in 2 minutes

A synthetic DNA binding compound has proved surprisingly effective at binding to the DNA of bacteria and killing all the bacteria it touched within two minutes.

8 Jun 2009

Abbott and AstraZeneca to co-promote Trilipix (fenofibric acid)

Abbot and AstraZeneca have announced that they have entered into an agreement for AstraZeneca to co-promote Abbott's Trilipix (fenofibric acid), a medication for use alone or in combination with a statin to treat certain lipid disorders. Under the terms of the agreement, AstraZeneca will obtain the non-exclusive right to co-promote Trilipix alongside Abbott in the United States, excluding Puerto Rico. Specific financial terms were not disclosed.

5 Jun 2009

Economic downturn pushes cost of medicines up, pharmacists lobby for reform role

"Even with the Medicare drug benefit, even with the prevalence of low-cost generics, even with loss-leader discounting by big chains, many Americans still find themselves unable to afford the prescription medications that manage their life-threatening conditions," The New York Times reports.

4 Jun 2009

Promising antimicrobial agent kills viruses, stimulates immune system

A promising antimicrobial agent already known to kill bacteria can also kill viruses and stimulate the innate immune system, according to researchers at National Jewish Health.

4 Jun 2009

FDA moves towards greater openness

The Associated Press reports that FDA Commissioner Margaret Hamburg "announced Tuesday she has created a task force to make recommendations on how the agency can release more information in such areas as drug evaluation and enforcement matters. She wants a report in six months."

3 Jun 2009